Authors:
Schmalfeldt, B
Prechtel, D
Harting, K
Spathe, K
Rutke, S
Konik, E
Fridman, R
Berger, U
Schmitt, M
Kuhn, W
Lengyel, E
Citation: B. Schmalfeldt et al., Increased expression of matrix metalloproteinases (MMP)-2, MMP-9, and the urokinase-type plasminogen activator is associated with progression from benign to advanced ovarian cancer, CLIN CANC R, 7(8), 2001, pp. 2396-2404
Authors:
Lengyel, E
Schmalfeldt, B
Konik, E
Spathe, K
Harting, K
Fenn, A
Berger, U
Fridman, R
Schmitt, M
Prechtel, D
Kuhn, W
Citation: E. Lengyel et al., Expression of latent matrix metalloproteinase 9 (MMP-9) predicts survival in advanced ovarian cancer, GYNECOL ONC, 82(2), 2001, pp. 291-298
Authors:
Kleifeld, O
Kotra, LP
Gervasi, DC
Brown, S
Bernardo, MM
Fridman, R
Mobashery, S
Sagi, I
Citation: O. Kleifeld et al., X-ray absorption studies of human matrix metalloproteinase-2 (MMP-2) boundto a highly selective mechanism-based inhibitor - Comparison with the latent and active forms of the enzyme, J BIOL CHEM, 276(20), 2001, pp. 17125-17131
Authors:
Dong, Z
Nemeth, JA
Cher, ML
Palmer, KC
Bright, RC
Fridman, R
Citation: Z. Dong et al., Differential regulation of matrix metalloproteinase-9, tissue inhibitor ofmetalloproteinase-1 (TIMP-1) and TIMP-2 expression in co-cultures of prostate cancer and stromal cells, INT J CANC, 93(4), 2001, pp. 507-515
Authors:
Hernandez-Barrantes, S
Shimura, Y
Soloway, PD
Sang, QXA
Fridman, R
Citation: S. Hernandez-barrantes et al., Differential roles of TIMP-4 and TIMP-2 in Pro-MMP-2 activation by MT1-MMP, BIOC BIOP R, 281(1), 2001, pp. 126-130
Authors:
Kotra, LP
Cross, JB
Shimura, Y
Fridman, R
Schlegel, HB
Mobashery, S
Citation: Lp. Kotra et al., Insight into the complex and dynamic process of activation of matrix metalloproteinases, J AM CHEM S, 123(13), 2001, pp. 3108-3113
Authors:
Dong, Z
Ghabrial, M
Katar, M
Fridman, R
Berk, RS
Citation: Z. Dong et al., Membrane-type matrix metalloproteinases in mice intracorneally infected with Pseudomonas aeruginosa, INV OPHTH V, 41(13), 2000, pp. 4189-4194
Authors:
Toth, M
Bernardo, MM
Gervasi, DC
Soloway, PD
Wang, ZP
Bigg, HF
Overall, CM
DeClerck, YA
Tschesche, H
Cher, ML
Brown, S
Mobashery, S
Fridman, R
Citation: M. Toth et al., Tissue inhibitor of metalloproteinase (TIMP)-2 acts synergistically with synthetic matrix metalloproteinase (MMP) inhibitors but not with TIMP-4 to enhance the (membrane type 1)-MMP-dependent activation of pro-MMP-2, J BIOL CHEM, 275(52), 2000, pp. 41415-41423
Authors:
Olson, MW
Bernardo, MM
Pietila, M
Gervasi, DC
Toth, M
Kotra, LP
Massova, I
Mobashery, S
Fridman, R
Citation: Mw. Olson et al., Characterization of the monomeric and dimeric forms of latent and active matrix metalloproteinase-9 - Differential rates for activation by stromelysin 1, J BIOL CHEM, 275(4), 2000, pp. 2661-2668
Authors:
Hernandez-Barrantes, S
Toth, M
Bernardo, MM
Yurkova, M
Gervasi, DC
Raz, Y
Sang, QXA
Fridman, R
Citation: S. Hernandez-barrantes et al., Binding of active (57 kDa) membrane type 1-matrix metalloproteinase (MT1-MMP) to tissue inhibitor of metalloproteinase (TIMP)-2 regulates MT1-MMP processing and pro-MMP-2 activation, J BIOL CHEM, 275(16), 2000, pp. 12080-12089
Authors:
Upadhyay, J
Shekarriz, B
Nemeth, JA
Dong, Z
Cummings, GD
Fridman, R
Sakr, W
Grignon, DJ
Cher, ML
Citation: J. Upadhyay et al., Membrane type 1-matrix metalloproteinase (MT1-MMP) and MMP-2 immunolocalization in human prostate: Change in cellular localization associated with high-grade prostatic intraepithelial neoplasia, CLIN CANC R, 5(12), 1999, pp. 4105-4110
Citation: M. Toth et al., Biosynthesis of alpha 2(IV) and alpha 1(IV) chains of collagen IV and interactions with matrix metalloproteinase-9, J CELL PHYS, 180(1), 1999, pp. 131-139
Citation: Gy. Li et al., Tissue inhibitor of metalloproteinase-1 inhibits apoptosis of human breastepithelial cells, CANCER RES, 59(24), 1999, pp. 6267-6275
Authors:
Bianco, FJ
Gervasi, DC
Tiguert, R
Grignon, DJ
Pontes, JE
Crissman, JD
Fridman, R
Wood, DP
Citation: Fj. Bianco et al., Matrix metalloproteinase-9 expression in bladder washes from bladder cancer patients predicts pathological stage and grade, CLIN CANC R, 4(12), 1998, pp. 3011-3016